Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
LUMO Labs
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 20, 2025 Partnership Techcyte and Aiosyn collaborate to integrate AI-powered slide QC and mitotic counting into the Fusion digital pathology platform · aiosyn.com Nov 27, 2024 Launched Aiosyn launches AiosynQC Pulse for external digital slide quality assessments, providing pathology labs with insights for slide quality improvement · aiosyn.com May 22, 2024 Partnership Aiosyn and HistoWiz partner to improve kidney disease research through AI-powered preclinical and research studies. · keloland.com Feb 28, 2024 Launched Aiosyn Launches Kidney Image Analysis Services Through Its NephroPath Platform to Accelerate Drug Development Studies · businesswire.com Sep 18, 2023 Launched Aiosyn Introduces Kidney AI Platform to Revolutionize Renal Disease Research · DutchNews.nl 2021 Founded
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
Legal entity Aiosyn B.V. its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Teiko LabsVenture round $11.6M · 5 yr ago • 51-200 employees • 5 roles
Teiko is a CLIA-certified clinical laboratory serving both clinical trials and physicians. We provide CRO services for clinical trials and…
Book a lab test online and get tested at home in 60 mins with Orange Health - Certified diagnostic lab in Bangalore, Delhi, Mumbai…
Ahead HealthVenture round $10M · 2 mo ago • 51-200 employees
Early detection of cancer, liver disease and over 500 other diseases. Receive a personal health action plan with full body MRI and blood…
Qvin is the first and only healthcare service to scientifically prove menstrual blood can test for relevant health information - like a lab…
Farmako Healthcare11-50 employees
Home About Team Ask Farmako AI Delivering care,24/7 In critical moments, timely access to medicines makes a difference. Farmako delivers…
CurebaySeries B $21M · 16 mo ago • 2 roles
CureBay – for a healthier India. Order genuine medicines online, book lab tests, and consult doctors at affordable prices. Healthcare…

Overview

Aiosyn develops AI for histopathology, empowering pathologists in biopharma and clinical diagnostics. Our AI analyzes and quantifies stained tissue, returning reproducible read-outs to biopharma R&D and clinical laboratories.

News

Blog 27 days ago
Aiosyn launches new website for preclinical studies and clinical laboratories
Aiosyn has launched its new website that reflects its current focus: quantitative AI-based tissue analysis for preclinical studies and automated quality control for clinical laboratories.
Read more
Report
Blog 3 months ago
Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy
Published in the European Journal of Pharmaceutical Sciences: NephroPath AI quantified glomerulosclerosis and tubular impairment across whole kidney sections and resolved a dapagliflozin treatment effect that classical histopathological scoring did not de
Read more
Report
Blog 1 year ago
Dutch Aiosyn secures 2.4M funding to scale AI-powered cancer diagnostics
Aiosyn, a Dutch medical software company specializing in AI-powered pathology, has successfully closed a €2.4 million funding round. Participating investors are TNO Ventures, Oost NL, LUMO Labs, and Health Innovations.
Read more
Report
Blog 1 year ago
Aiosyn and Telemis advance breast cancer diagnosis with IVDR-certified AI technology
The integration will enable labs to use Aiosyn Mitosis Breast, the first IVDR-certified breast cancer diagnosis AI tool for mitosis counting
Read more
Report
Blog 1 year ago
Navigating the IVDR: How Aiosyn prioritized compliance from day one
Aiosyn avoided the transition period to IVDR and potential delays by being IVDR-compliant from day one, ensuring smoother market access and increased credibility
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1